Combined inhibition of <scp>EZH</scp>2 and histone deacetylases as a potential epigenetic therapy for non‐small‐cell lung cancer cells
Taichi Takashina(Hokkaido University), Hirotoshi Dosaka‐Akita(Hokkaido University)
Cited by 63
Related Papers
Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant
|British Journal of Cancer|2008|33
Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells
|British Journal of Cancer|2008|18